Molecular Templates, Inc. Announces Fast Track Designation Granted by FDA for MT-6402 Nov 18, 2021 8:00am EST
Molecular Templates to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit Sep 20, 2021 8:00am EDT
Molecular Templates, Inc. Announces Dosing of First Subject in Phase 1 Study of MT-6402 in PD-L1-Positive Solid Tumors Jul 09, 2021 8:00am EDT
Molecular Templates to Present at the Ladenburg Thalmann 2021 Healthcare Conference Jul 06, 2021 8:00am EDT
Molecular Templates Announces Poster Presentations on its Engineered Toxin Bodies at the American Association of Cancer Research (AACR) Virtual Annual Meeting I Apr 12, 2021 7:00am EDT
